Despite receiving more than 600 reports of "adverse events" for medicinal cannabis in the past three years, the Therapeutic Goods Administration (TGA) is yet to investigate the safety of most ...

Crypto markets will enter “up only” mode once the United States Treasury hits its target goal of filling the General Account (TGA), the Treasury Department’s bank account, with $850 billion, according ...

US President Donald Trump has attracted swift criticism from global medical experts after claiming paracetamol can cause autism in babies. Source: Getty Australia’s top medical experts have stressed ...

Tylenol’s manufacturer Kenvue Inc. flatly refutes the expected claims. The Washington Post reported that officials also intend to promote research into whether the drug leucovorin could potentially be ...

The official story of the job market is finally catching up to the harsh reality. Job seekers have complained for some time now—to me, their friends, pets or anyone who will listen—that it is ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Medical and pharmaceutical experts are reassuring people that paracetamol is safe to use during pregnancy, despite Donald Trump saying there is a link to babies developing autism. Doctors say that ...

The Therapeutic Goods Administration has revealed it will consider in-house SPF testing after a CHOICE sunscreen report found many popular products had much lower levels than advertised. The latest ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Add articles to your saved list and come back to them any time. There is no link between taking paracetamol during pregnancy and an increased risk of autism in children, multiple experts have said, ...

Eisai and Biogen (BIIB) announced that the Therapeutic Goods Administration, TGA,of Australia has approved the humanized anti-soluble aggregated amyloid-beta monoclonal antibody “LEQEMBI” for mild ...